Skip to main content

Zannes Maria's Form 4 filing

bioAffinity Technologies, Inc. (BIAF) · filed Nov 22, 2022

Accession no.
0001493152-22-033283
Filed
Nov 22, 2022, 1:54 PM ET
Trade date
Aug 31-Nov 17, 2022
Filing delay
83 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 4 derivative transactions. It was filed 83 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Zannes MariaCIK 0001481928Director, Officer (President, CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 31, 2022Common StockPPurchaseAcquired+16,326––19,897Direct
Sep 6, 2022Common StockCConversionAcquired+23,672$4.20+$99,422.443,569Direct
Nov 17, 2022Common StockAGrant or awardAcquired+18,099$0.00$061,668Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 31, 2022Common StockPPurchaseAcquired+16,326––16,326Direct
Aug 31, 2022Common StockPPurchaseAcquired+16,326––16,326Direct
Sep 6, 2022Common StockCConversionDisposed−23,672$0.00–0Direct
Sep 6, 2022Common StockAGrant or awardAcquired+23,571––23,571Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)